1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
Svenningsson, Per ; Odin, Per LU ; Dizdar, Nil ; Johansson, Anders ; Grigoriou, Sotirios LU
; Tsitsi, Panagiota
; Wictorin, Klas
LU
; Bergquist, Filip
; Nyholm, Dag
LU
and Rinne, Juha
, et al.
(2020)
In Movement Disorders
35(6).
p.1046-1054
Mark
- 2018
- Use of flutemetamol F18-labeled positron emission tomography and other biomarkers to assess risk of clinical progression in patients with amnestic mild cognitive impairment
-
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia
Jansen, Willemijn J. ; Ossenkoppele, Rik LU ; Tijms, Betty M. ; Fagan, Anne M. ; Hansson, Oskar LU
; Klunk, William E.
; Van Der Flier, Wiesje M.
; Villemagne, Victor L.
; Frisoni, Giovanni B.
and Fleisher, Adam S.
, et al.
(2018)
In JAMA Psychiatry
75(1).
p.84-95
Mark
- Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
- 2015
- Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
- 1997
-
Genetic polymorphism of catechol-O-methyltransferase (COMT) : Correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland
Syvänen, Ann Christine ; Tilgmann, Carola LU
; Rinne, Juha
and Ulmanen, Ismo
(1997)
In Pharmacogenetics
7(1).
p.65-71
Mark